These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25875673)

  • 1. Rhododendrol-induced leukoderma accompanied by allergic contact dermatitis caused by a non-rhododendrol skin-lightening agent, 5,5'-dipropylbiphenyl-2,2'-diol.
    Yagami A; Suzuki K; Sano A; Takahashi M; Kobayashi T; Morita Y; Ando A; Iwata Y; Matsunaga K
    J Dermatol; 2015 Jul; 42(7):739-40. PubMed ID: 25875673
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis caused by a skin-lightening agent, 5,5'-dipropylbiphenyl-2,2'-diol. A comment.
    Roberts DW; Aptula AO
    Contact Dermatitis; 2012 Jun; 66(6):357-9. PubMed ID: 22568852
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergic contact dermatitis caused by a skin-lightening agent, 5,5'-dipropylbiphenyl-2,2'-diol.
    Suzuki K; Yagami A; Matsunaga K
    Contact Dermatitis; 2012 Jan; 66(1):51-2. PubMed ID: 22150905
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma.
    Arase N; Tanemura A; Jin H; Nishioka M; Aoyama Y; Oiso N; Matsunaga K; Suzuki T; Nishigori C; Kawamura T; Shimizu T; Ito A; Fukai K; Abe Y; Yang L; Tsuruta D; Takeoka K; Iwatani Y; Hidaka Y; Nishida M; Yamauchi-Takihara K; Arase H; Fujimoto M; Katayama I
    J Dermatol Sci; 2019 Aug; 95(2):80-83. PubMed ID: 31399283
    [No Abstract]   [Full Text] [Related]  

  • 5. Open-label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol-induced refractory leukoderma.
    Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Tada Y; Watanabe S
    J Dermatol; 2018 Nov; 45(11):1283-1288. PubMed ID: 30156328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention of pigment stem cells in Rhododenol-induced leukoderma: Pathological investigation of 11 patients.
    Watanabe S; Yagami A; Iwata Y; Nagai A; Kuroda M; Sugiura K; Matsunaga K
    J Dermatol; 2017 Jul; 44(7):e148-e149. PubMed ID: 28516676
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemical-Induced Vitiligo.
    Harris JE
    Dermatol Clin; 2017 Apr; 35(2):151-161. PubMed ID: 28317525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrophotometrical analysis of rhododendrol-induced leucoderma using a novel multispectral camera.
    Inoue M; Kikuchi K; Watabe A; Yamasaki K; Aiba S
    Br J Dermatol; 2016 Aug; 175(2):334-9. PubMed ID: 26991967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic contact dermatitis caused by phenylethyl resorcinol [4-(1-phenylethyl)-1,3-benzenediol], a skin-lightening agent in cosmetics.
    Gohara M; Yagami A; Suzuki K; Morita Y; Sano A; Iwata Y; Hashimoto T; Matsunaga K
    Contact Dermatitis; 2013 Nov; 69(5):319-20. PubMed ID: 24117746
    [No Abstract]   [Full Text] [Related]  

  • 10. Substantial evidence for the rhododendrol-induced generation of hydroxyl radicals that causes melanocyte cytotoxicity and induces chemical leukoderma.
    Gabe Y; Miyaji A; Kohno M; Hachiya A; Moriwaki S; Baba T
    J Dermatol Sci; 2018 Sep; 91(3):311-316. PubMed ID: 30005897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma.
    Tokura Y; Fujiyama T; Ikeya S; Tatsuno K; Aoshima M; Kasuya A; Ito T
    J Dermatol Sci; 2015 Mar; 77(3):146-9. PubMed ID: 25726326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of rhododendrol inhibition of NF-κB on melanocytes in the presence of tyrosinase.
    Arase N; Yang L; Tanemura A; Yang F; Suenaga T; Arase H; Katayama I
    J Dermatol Sci; 2016 Aug; 83(2):157-9. PubMed ID: 27174091
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergic contact dermatitis caused by phenylethyl resorcinol, a skin-lightening agent contained in a sunscreen.
    Pastor-Nieto MA; Sánchez-Pedreño P; Martínez-Menchón T; Melgar-Molero V; Alcántara-Nicolás F; de la Cruz-Murie P
    Contact Dermatitis; 2016 Oct; 75(4):250-3. PubMed ID: 27620125
    [No Abstract]   [Full Text] [Related]  

  • 14. Zebrafish as a new model for rhododendrol-induced leukoderma.
    Hayazaki M; Hatano O; Shimabayashi S; Akiyama T; Takemori H; Hamamoto A
    Pigment Cell Melanoma Res; 2021 Nov; 34(6):1029-1038. PubMed ID: 34310852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leukoderma caused by chemicals: mechanisms underlying 4-alkyl/aryl-substituted phenols- and rhododendrol-induced melanocyte loss].
    Nishimaki-Mogami T
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2015; (133):13-20. PubMed ID: 26821466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic contact dermatitis caused by arbutin and dipotassium glycyrrhizate in skin-lightening products.
    Oiso N; Tatebayashi M; Hoshiyama Y; Kawada A
    Contact Dermatitis; 2017 Jul; 77(1):51-53. PubMed ID: 28612442
    [No Abstract]   [Full Text] [Related]  

  • 17. 4-(4-hydroroxyphenyl)-2-butanol (rhododendrol) activates the autophagy-lysosome pathway in melanocytes: insights into the mechanisms of rhododendrol-induced leukoderma.
    Yang L; Yang F; Wataya-Kaneda M; Tanemura A; Tsuruta D; Katayama I
    J Dermatol Sci; 2015 Mar; 77(3):182-5. PubMed ID: 25680854
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of allergic contact dermatitis caused by arbutin.
    Matsuo Y; Ito A; Masui Y; Ito M
    Contact Dermatitis; 2015 Jun; 72(6):404-5. PubMed ID: 25752782
    [No Abstract]   [Full Text] [Related]  

  • 19. Allergic contact dermatitis caused by 3-o-ethyl-L-ascorbic acid (vitamin C ethyl).
    Yagami A; Suzuki K; Morita Y; Iwata Y; Sano A; Matsunaga K
    Contact Dermatitis; 2014 Jun; 70(6):376-7. PubMed ID: 24846587
    [No Abstract]   [Full Text] [Related]  

  • 20. Guide for medical professionals (i.e., dermatologists) for the management of Rhododenol-induced leukoderma.
    Nishigori C; Aoyama Y; Ito A; Suzuki K; Suzuki T; Tanemura A; Ito M; Katayama I; Oiso N; Kagohashi Y; Sugiura S; Fukai K; Funasaka Y; Yamashita T; Matsunaga K
    J Dermatol; 2015 Feb; 42(2):113-28. PubMed ID: 25622988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.